Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$49.7 - $57.71 $82,999 - $96,375
-1,670 Reduced 24.39%
5,178 $263,000
Q2 2022

Aug 10, 2022

BUY
$63.83 - $80.0 $57,447 - $72,000
900 Added 15.13%
6,848 $440,000
Q1 2022

May 11, 2022

SELL
$76.85 - $89.45 $14,294 - $16,637
-186 Reduced 3.03%
5,948 $461,000
Q4 2021

Feb 10, 2022

SELL
$74.57 - $87.19 $13,049 - $15,258
-175 Reduced 2.77%
6,134 $526,000
Q3 2021

Nov 12, 2021

SELL
$73.77 - $83.61 $36,885 - $41,805
-500 Reduced 7.34%
6,309 $508,000
Q2 2021

Aug 11, 2021

SELL
$80.5 - $88.01 $19,803 - $21,650
-246 Reduced 3.49%
6,809 $548,000
Q1 2021

May 12, 2021

SELL
$76.38 - $86.03 $4,888 - $5,505
-64 Reduced 0.9%
7,055 $595,000
Q3 2020

Nov 12, 2020

SELL
$78.33 - $90.73 $188,070 - $217,842
-2,401 Reduced 25.22%
7,119 $573,000
Q2 2020

Aug 12, 2020

BUY
$78.66 - $94.14 $38,071 - $45,563
484 Added 5.36%
9,520 $819,000
Q1 2020

Apr 28, 2020

BUY
$71.57 - $93.3 $284,132 - $370,401
3,970 Added 78.37%
9,036 $734,000
Q4 2019

Feb 06, 2020

SELL
$76.7 - $88.45 $15,033 - $17,336
-196 Reduced 3.72%
5,066 $424,000
Q1 2019

May 14, 2019

BUY
$64.48 - $81.31 $9,865 - $12,440
153 Added 2.99%
5,262 $428,000
Q3 2018

Nov 14, 2018

BUY
$70.71 - $77.75 $361,257 - $397,224
5,109 New
5,109 $394,000
Q2 2018

Aug 10, 2018

SELL
$63.43 - $75.41 $324,063 - $385,269
-5,109 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$62.56 - $72.26 $11,260 - $13,006
180 Added 3.65%
5,109 $0
Q3 2017

Nov 07, 2017

BUY
$59.5 - $64.61 $293,275 - $318,462
4,929
4,929 $310,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.5B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Glenview Trust CO Portfolio

Follow Glenview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Trust CO with notifications on news.